Page last updated: 2024-11-04

sulfobromophthalein and Cardiomyopathy, Hypertrophic

sulfobromophthalein has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morishima, A1
Nomura, S1
Otani, N1
Miya, T1
Morimoto, K1
Sekine, I1
Murata, M1

Other Studies

1 other study available for sulfobromophthalein and Cardiomyopathy, Hypertrophic

ArticleYear
[Constitutional indocyanine green excretory defect with hypertrophic cardiomyopathy--a case with rare hepatocellular cytoplasmic inclusions].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1982, Oct-10, Volume: 71, Issue:10

    Topics: Cardiomyopathy, Hypertrophic; Humans; Inclusion Bodies; Indocyanine Green; Liver; Liver Diseases; Li

1982